(Hypertension. 1995;25:124-131.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Pathology, University of Heidelberg (K.A., H.G.), and the Department of Pathology, Städtische Kliniken Darmstadt (S.S., G.M.) (Germany).
Correspondence to Prof Dr Gerhard Mall, Pathologisches Institut der Städtischen, Kliniken Darmstadt Grafenstr 9, D-64283 Darmstadt, FRG.
| Abstract |
|---|
|
|
|---|
Key Words: hypertrophy hyperplasia muscle, smooth arteries rats, inbred SHR
| Introduction |
|---|
|
|
|---|
In the present investigation, we compared growth parameters of small intramyocardial arteries of stroke-prone SHR (SHRSP) with those of normotensive Wistar-Kyoto (WKY) controls. By means of extrapolation of measurements on two-dimensional histological sections into the three-dimensional space, we determined the arterial length, arterial wall volume, and, for the first time, mean volume and number of intramyocardial arterial SMCs as well as the mean volume of cell nuclei. We used recently developed stereological techniques (the orientator, the nucleator, and the selector) for the unbiased determination of mean cell and nuclear volumes as well as the number of cells from histological sections.
| Methods |
|---|
|
|
|---|
For quantitative morphological investigations, the viscera were fixed by retrograde vascular perfusion via the abdominal aorta with rats under 10% chloralhydrate anesthesia at a pressure of 110 mm Hg as described elsewhere.17 After perfusion, the hearts were carefully excised, and right and left ventricle weights were determined with a precision balance. From the left ventricles, including the intraventricular septa, probes with independent uniform random orientation in space were prepared according to the orientator technique.18 Briefly, this technique generates isotropic orientation of histological sections in space (IUR) in a random systematic manner that increases analysis efficiency by reducing variance. In practice, the hearts were cut into 1-mm-thick transversal sections beginning at the apex using a razor blade. The slices were then put onto a grid with 100 grid points using random numbers. Two slices were selected for further preparation. The specimens were temporarily embedded in a circular cylinder consisting of agar (Merck Co). Two sets of four sections were generated by systematic cutting of the agar cylinder with a razor blade according to the orientator technique. Thus, thin tissue slices were produced and embedded in Epon-Araldite (Serva Co). Semithin sections (1-µm) were prepared and stained with methylene blue and basic fuchsin.17 In addition, the remaining parallel slices of the left ventricles were embedded in paraffin (Cambridge Instrument Co) and stained with silver and nuclear fast red as described elsewhere.19
Stereological Technique
Various definitions of arteries are in use today. Some
investigators have classified arteries, arterioles, and capillaries
according to their diameters.20 21 However, diameters
depend on the arterial size as well as on the contractile state of
vascular SMCs. Therefore, we preferred a qualitative definition of
arteries for our study. Small intramyocardial arteries were identified
according to Wiest et al19 as vessels having a complete
layer of SMCs separated from the endothelium by a continuous basement
membrane, ie, without any myoendothelial contact.22 A
subclassification into arterioles, terminal arterioles, and
precapillary sphincters was not made.
Total Length of Intramyocardial Arteries
Length density, LV (length of one-dimensional
structures per unit reference volume), was derived from counts on
paraffin sections according to LV=CxQA, with
QA being the number of arterial sectional transects per
unit sectional area and C the coefficient of correction. C was
empirically determined as described elsewhere.19
QA of arteries was counted as a final magnification of
160:1 using a Zeiss eyepiece with an integrated square area of 0.468
mm2 ("true" area corrected for tissue shrinkage after
embedding in paraffin). Squares were superimposed on all histological
sections (mean total sectional area, 500 mm2). An average
of at least 500 arteries per animal were counted. The total length
(Lart) of the arterial tree was determined as
Lart (mm)=LV (mm/mm3)xV
(mm3). The left ventricular volume V (mm3) was
derived from the left ventricular weight (LVW) divided by the specific
weight of perfusion-fixed hearts (1.04 mg/mm3) according to
V (mm3)=LVW/1.04 mg/mm3.
Arterial Wall Volume, Wall Thickness, and Wall-Lumen Ratio of Small
Intramyocardial Arteries
For determination of the arterial wall volume
(vwall), eight orientator semithin sections per animal were
analyzed at a final magnification of 400:1 using the semiautomatic
image-analysis system Videoplan (Kontron Co). The ratio of
sectional area of arterial walls per reference sectional area of the
myocardium (AA) was determined.
Since AA (area per reference area)=VV (volume per reference volume), the total volume of the left ventricular arterial wall (vwall) could be derived from the total left ventricular volume (V).
Wall thickness and minimal lumen diameter of small intramyocardial arteries were measured on eight semithin orientator sections per animal at a final magnification of 1000:1 using oil immersion and a Videoplan computer. Wall thickness was calculated as the mean of two opposite measurements in the direction of the minimal diameter. This direction was chosen because the minimal lumen diameter is less affected by the sectioning angle than any other direction. Wall thickness is also minimal in the direction of the minimal lumen diameter; thus, planimetric measurements at this site are less affected by cutting artifacts. The wall-lumen ratio was calculated from wall thickness divided by the minimal lumen diameter.
Structure of the Arterial Wall
(VVcells=vcells/vwall)
For determination of the volume fraction of cellular
(VVcells) and extracellular matrix of SMCs in the wall of
intramyocardial arteries, plastic sections were quantitatively
investigated by point counting using a 100-point grid (Zeiss Co). The
percentage of the extracellular volume fraction was determined on
0.5-µm semithin sections stained with methylene blue and basic
fuchsin. Additionally, qualitative ultrastructural investigations were
performed at various magnifications using a Zeiss EM 10 on several
ultrathin sections per animal.
Mean Cell Volume and Mean Nuclear Volume of Arterial SMCs
The nucleator method23 24 demands that IUR
sections be used for determination of the mean volume of arterial SMCs
(vcell). This allows an unbiased estimation of the mean
volume from a three-dimensional random sample of nuclei that was gained
by a series of eight equally distanced semithin histological sections.
For practical reasons, a set of eight parallel section planes at an
interval of approximately 1 µm was gained from one orientator tissue
probe. The investigations were performed on eight orientator probes per
animal with every orientator section cut into eight serial sections,
resulting in a total of 64 sections per animal. The sections were
analyzed at a final magnification of 1000:1 using oil immersion and a
Videoplan computer.
For preparation of the set of eight parallel sections, the following criteria must be fulfilled: (1) The distance of two serial sections has to be big enough to gain a visible change in organ structure but must also be small enough to compare the serial structures with each other. (2) This implies for the present study that the distance between two serial sections has to be smaller than the smallest nuclear diameter in any direction to avoid loss of small nuclei.
For practical measurements, one has to choose an isotropic uniform random section plane, the so-called lookup plane. Afterwards, a parallel section plane, the so-called measure or reference plane (ie, a second histological section at a certain distance from the first one), was chosen on which the measurements were performed. Comparison of the serial sections was performed by using a set of two microscopes and a video camera for permanent visualization of the lookup plane and measurements on the reference plane.
A cell profile is sampled on the measure plane if its nucleus is visible, provided that it is not detectable on the lookup plane. Then, a grid of 100 test points (Zeiss Co) is projected onto the section, and whenever a sampled nucleus is hit by a test point, the length of a random cell intercept through this point is determined. The lengths between the cell boundaries and the grid point are determined as l+ and l-. These parameters were measured in every sampled cell, and the procedure was repeated three times per cell (with 30°, 90°, and 150° direction) giving l1+, l1-, l2+, l2-, l3+, and l3- (see Fig 1).
|
The mean intercepts for each direction l1, l2, and l3 were determined as
![]() |
![]() |
![]() |
The mean intercept length in the third power per cell
(lo3) was then determined by the equation lo3=
(l13+l23+l33).
Afterwards, the cell volume (vo) and the estimated mean
cell volume in the numerical distribution (vN) were
determined according to the following equations
![]() |
![]() |
![]() |
with n the number of sampled cells.
The mean nuclear volume (vnucleus) was
estimated by using the selector method.25 26 This method
is appropriate for determination of the mean volume of particles
without subcomponents. After three-dimensional sampling of nuclei as
described above, the volume of each particle was estimated from
point-sampled intercepts by using the same optical system as that for
the nucleator. Again, three directions (30°, 90°, and 150°) were
chosen, leading to the nuclear intercepts l1,
l2, and l3. The mean nuclear intercept
(lo) in the third power was determined according to the
equation lo3=l13+l23+l33.
The mean nuclear volume (vo) was derived from
vo=
/3xlo3. For n measurements,
vN was determined as
vN=
/3(l013+l023+. . .+l0n3)/n.
Number of Arterial SMCs
In addition to the volume of arterial SMCs, the number of SMCs
(ncell) of the arterial walls was derived from the total
volume of nonendothelial wall cells (Vwall) and the mean
volume of SMCs (vN) following the equation ncell=Vwall/vN.
Volume of Intramyocardial Fibrosis and Volume Density of
Intramyocardial Nonvascular Interstitium
The volume of intramyocardial fibrosis [V(fib)] was
determined using Sirius redstained 4-µm paraffin sections of the
heart. The area fraction (AA) of red-stained collagen was
determined using an automatic image-analysis system (IBAS II,
Kontron Co) on the basis of gray-value discrimination (for details, see
Reference 55 ).
Since AA(fib)=VV(fib), the total volume of left ventricular intramyocardial fibrosis [V(fib)] could be derived from the total left ventricular volumexVV(fib).
Volume density of intramyocardial nonvascular interstitium was determined on eight semithin sections per animal by point counting using a 100-point test grid (Zeiss) according to PP=VV (for details, see Reference 55 ).
Statistics
The arithmetic means of the absolute stereological parameters
were compared using Student's t test.27 Data
are expressed as mean±SD and mean±SEM (Table 2).
|
| Results |
|---|
|
|
|---|
|
In our study, 49 to 287 small intramyocardial arteries per animal (WKY, 97.2±49.4; SHRSP, 117.5±85.8) were investigated with the nucleator method. The lumen diameters ranged from 20 to 140 µm, with most ranging from 20 to 60 µm. The mean lumen diameter of intramyocardial arteries was comparable in both groups (34.6±1.50 and 33.4±1.47 µm, respectively), whereas wall thickness and the wall-lumen ratio were significantly (P<.01 and P<.001) increased in SHRSP. Concomitantly, total left ventricular arterial wall volume was considerably higher in SHRSP (+237% versus WKY, P<.001, Table 2 and Figs 2 and 3). The total length of intramyocardial arteries was slightly higher in SHRSP (+18%, P<.05). Thus, length increase of arteries corresponded to the increase in absolute left ventricular weight.
|
|
Fig 4 shows the distribution of intramyocardial arterial wall thickness and corresponding lumen diameters. This frequency histogram indicates that vessels with a smaller wall thickness are overrepresented in WKY rats, whereas in SHRSP, vessels with a larger wall thickness are more frequent. The figure further shows a smaller arterial lumen for any given wall thickness in SHRSP compared with WKY rats. The arterial wall thickening was caused by hypertrophy of vascular SMCs because the mean cell volumes of SMCs of arterial walls were nearly doubled in SHRSP (+81%, P<.01) compared with WKY rats. Significant differences between the two groups were also found for nuclear volume, whereas the ratio of nuclear volume to cellular volume was not significantly changed. This indicates that hypertrophy is caused by an increase in cell cytoplasm as well as in nuclear volume. The number of SMCs in arterial walls (+104%, P<.05) and the number of arterial SMCs per millimeter of arterial length were significantly increased in SHRSP (+29%, P<.05). As shown in Fig 3, the media of small intramyocardial arteries is largely composed of SMCs (>95%) that are closely connected. Therefore, the percentage of extracellular matrix is only approximately 4% (SHRSP, 6.5±1.8%; WKY, 2.3±1.2%) of the total wall volume as detected by our measurements. Consequently, for our stereological measurements, we regarded the arterial wall as completely composed of SMCs and divided the total arterial wall volume by the mean cell volume of SMCs to get the mean cell number.
|
| Discussion |
|---|
|
|
|---|
Myocardial growth processes in hypertension may be adaptive to myocardial hypertrophy, ie, enlargement of myofibers, or may result from pressure increase itself or from hypertension-associated factors, such as hormones. Therefore, we recently studied the length increase of the intramyocardial arterial tree during physiological growth19 and found similar growth rates in WKY rats and SHRSP, indicating adaptive lengthening in SHRSP in good correlation with the increase in absolute left ventricular weight. Evidently, arterial length increase is caused by hyperplasia of arterial SMCs and not by hypertrophy. On the other hand, the number of arterial SMCs per unit arterial length was significantly increased in SHRSP and contributed to wall thickening.
The problem of vascular SMC hypertrophy versus hyperplasia in hypertension has been addressed so far by several investigators in many different ways, leading to controversial results. The model of hypertension, the animal model, the type and topography of arteries in the study, and the methodological approach therefore were critical parameters. For example, in slow-developing models of hypertension (SHR; two-kidney, one clip hypertension), the major growth response in large arteries (ie, the aorta) was found to be hypertrophy of SMCs rather than hyperplasia.7 8 13 28 29 30 The results are somewhat different if models of acute pressure overload (abdominal aortic stenosis) are investigated, in which predominantly hyperplasia was found.31 32 Therefore, it is tempting to speculate that the sort and degree of wall stress applied could be responsible for different types of cellular reactions.
However, major differences may exist between the SHR and two-kidney, one clip model, especially as far as the onset and extent of hypertension are concerned. On the other hand, the well-known biological variability in SHR and WKY rats may help to explain the controversial experimental findings.33 In our study, we concentrated on long-standing hypertension in 9-month-old SHRSP compared with normotensive WKY controls. Although we know that there are important differences in the genetics of both rat strains and that the use of WKY rats as a control for SHR has been criticized,34 35 36 37 we decided to introduce WKY rats as a normotensive control group. We are aware of the fact that the comparison of these two strains may be somewhat problematic, so we would like to emphasize that the data obtained in our study should be referred only to the strains we used.
Several vascular territories in hypertension have been investigated using various techniques and different animal models. Mulvany et al9 found wall thickening due to hyperplasia but not to hypertrophy of SMCs in third-order mesenteric arteries of prehypertensive SHR, thus indicating a difference between WKY rats and prehypertensive SHR that is not related to hypertension itself. This finding was supported by Lee et al,38 who demonstrated hyperplasia in mesenteric arteries of SHR. Additionally, Owens et al39 found hyperplasia in small mesenteric arteries of SHR compared with WKY rats. In larger arteries, however, Owens and Schwartz7 found no hyperplasia but hypertrophy of vascular SMCs in hypertension.
Evidently, true three-dimensional estimators of absolute numbers and volumes are superior to other approaches. In 1985 Mulvany et al9 introduced a stereological method (the dissector) that allowed the unbiased three-dimensional estimation of the number of nuclei in arterial walls. Compared with the dissector, which can only give nuclei number and volume, our method, the nucleator, offers a clear advantage: possible estimation of true cell volume and number. Additionally, in contrast to the dissector method, our method does not demand knowledge of the exact section thickness, facilitating the analysis.
Two-dimensional methods for the investigation of cellular reactions (counting of the number of SMCs on serial sections) were established by Loud et al40 but failed to contribute to solving the problem of hypertrophy and hyperplasia per se. Olivetti et al28 29 performed a morphometric analysis in the aorta of postnatal SHR and WKY rats and found hypertrophy and hyperplasia in young SHR. As in our study, hypertrophy (+68%) was found to be the predominant process underlying the aortic tissue response to early hypertension. Cellular hyperplasia (+21%) was found to occur later as some sort of consolidation of the adaptive process. Additionally, Owens and Schwartz7 8 as well as Owens and Reidy31 performed DNA measurements combined with direct measurements of cell number to further address the problem of hypertrophy and hyperplasia in vascular remodeling and found hyperplasia to be involved in hypertension.
Considering the finding of hyperplasia in mesenteric arteries of prehypertensive SHR, one may speculate that the higher level of arterial smooth muscle in SHR cells is genetically determined and not a consequence of hypertension.9 On the other hand, cellular hypertrophy in established hypertension was demonstrated to be related to or at least augmented by an increase in wall tension.28 Some studies investigated the influence of antihypertensive treatment in renovascular and genetic hypertension14 15 and did not find any difference in cell number but a decrease in cell volume after treatment with angiotensin-converting enzyme inhibitors. These findings also support the hypothesis that hypertrophy rather than hyperplasia is the direct consequence of chronic pressure overload.
In contrast, several studies clearly showed vascular hypertrophy in prehypertensive SHR,38 41 42 thus documenting the fact that vascular SMC hypertrophy could be clearly separated from pressure changes. It is speculated that other factors, such as hormones, an increased responsiveness to growth factors (ie, epidermal growth factor43 ), and an increased noradrenergic activity in SHR,44 may play a role in pressure-independent vascular changes in SHR. In addition, Head45 and Donohue et al46 postulated a possible role for trophic factors (ie, nerve growth factor) in young SHR providing the setting for the development of hypertension. Morton et al47 suggested a trophic influence of the renin-angiotensin system on the development of structural changes in SHR during the early onset of experimental hypertension. In contrast, cardiac hypertrophy in genetic hypertension (SHR) was found to be closely related to an increase in blood pressure.44 48 It is therefore tempting to speculate that structural alterations of small intramyocardial arteries in SHRSP may be influenced by both structural and hemodynamic factors.
Being the first three-dimensional analysis of intramyocardial arteries in SHRSP, our study has several limitations. As mentioned above, differences in the mean pressure in intramyocardial arteries, the thoracic aorta, and the mesenteric resistance vessels may induce different cellular reactions. The mean volumes of SMCs of intramyocardial arteries in this study are lower than the volumes reported for larger arteries.30 This may be related to differences in the animal model as well as to differences in vascular territories, but effects of different methods cannot be formally excluded. The investigations performed so far indicate that both aspects must be taken into consideration.
In summary, left ventricular myocardial hypertrophy in SHRSP is associated with an adaptive compensatory length increase of intramyocardial arteries (+18%) that is caused by hyperplasia of arterial SMCs. In contrast, intramyocardial arterial wall thickening in SHRSP is the result of hypertrophy (+80%) and hyperplasia (+104%). Further stereological studies should be performed on intramyocardial arteries in prehypertensive SHRSP to answer the question of whether cellular hyperplasia is inborne or pressure induced.
| Acknowledgments |
|---|
Received March 25, 1994; first decision May 9, 1994; accepted September 8, 1994.
| References |
|---|
|
|
|---|
2. Strauer BE. Das Hochdruckherz, Pathophysiologie-Diagnostic- Therapie. Berlin, FRG: Springer-Verlag; 1983.
3. Anderson PG, Bishop SP, Digerness SB. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ Res. 1989;64:1127-1136. [Abstract]
4. Vogt M, Motz W, Schwartzkopff B, Strauer BE. Coronary microangiopathy and cardiac hypertrophy. Eur Heart J. 1990;11(suppl B):133-138.
5. Amann K. Greber D, Gharehbaghi H, Wiest G, Lange B, Ganten U, Mattfeldt T, Mall G. Protective effects of nifedipine and moxonidine on cardiac structures in spontaneously hypertensive rats: stereological studies on myocytes, capillaries, arteries and cardiac interstitium. Am J Hypertens. 1992;5:76-83. [Medline] [Order article via Infotrieve]
6.
Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer
BE. Structural and functional alterations of the intramyocardial
coronary arterioles in patients with arterial hypertension.
Circulation. 1993;88:993-1003.
7.
Owens GK, Schwartz SM. Alterations in vascular smooth muscle
mass in the spontaneously hypertensive rat: role of cellular
hypertrophy, hyperploidy and hyperplasia. Circ Res. 1982;51:280-289.
8.
Owens GK, Schwartz SM. Vascular smooth muscle cell
hypertrophy and hyperploidy in the Goldblatt hypertensive rat.
Circ Res. 1983;53:491-501.
9.
Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for
hyperplasia in mesenteric resistance vessels of SHR using a three
dimensional dissector. Circ Res. 1985;57:794-800.
10. Inoue T, Masuda T, Kishi K. Structural and functional alterations in spontaneously hypertensive rats. Jpn Heart J. 1990;31:393-403. [Medline] [Order article via Infotrieve]
11. Bucher B, Travo P, Stocket JC. Smooth muscle cell hypertrophy and hyperplasia in the thoracic aorta of spontaneously hypertensive rats. Cell Biol Int Rep. 1984;8:567-577. [Medline] [Order article via Infotrieve]
12. Lee RMKW, Garfield RE, Forrest JB, Baniel EE. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels. 1983;20:57-71. [Medline] [Order article via Infotrieve]
13. Bevan RD, Van Marthens E, Bevan JA. Hyperplasia of vascular smooth muscle in experimental hypertension in the rabbit. Circ Res. 1976;38(suppl II):II-58-II-62.
14. Korsgaard N, Christensen KL, Mulvany MJ. Cellular morphology in mesenteric resistance vessels from antihypertensive treated spontaneously hypertensive rats. Basic Res Cardiol. 1991;86(suppl 1):33-41.
15. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Camilleri JP, Safar ME. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats. J Hypertens. 1988;6(suppl 3):S23-S25.
16. De Mey JGR, Dijkstra E, Fazzi G, Janssen G. Growth response in the arterial wall. Basic Res Cardiol. 1991;86(suppl 1):13-17.
17. Mall G, Schikora J, Mattfeldt T, Bodle R. Dipyridamole-induced capillary neoformation in the rat heart: a quantitative stereological study on papillary muscle. Lab Invest. 1987;57:86-93. [Medline] [Order article via Infotrieve]
18. Mattfeldt T, Mall G, Gharehbaghi H, Möller P. Estimation of surface area and length with the orientator. J Microsc. 1990;159:301-317. [Medline] [Order article via Infotrieve]
19. Wiest G, Gharehbaghi H, Amann K, Simon T, Mattfeldt T, Mall G. Physiologic growth of arteries in the rat heart parallels the growth of capillaries, but not of myocytes. J Mol Cell Cardiol. 1992;24:1423-1431. [Medline] [Order article via Infotrieve]
20. Engelson ET, Schmidt-Schönbein GW, Zweifach BW. The microvasculature in skeletal muscle, II: arteriolar network anatomy in normotensive and spontaneously hypertensive rats. Microvasc Res. 1986;31:356-374. [Medline] [Order article via Infotrieve]
21. Weiss HR, Conway RS. Morphometric study of the total and perfused arteriolar capillary network of the rabbit left ventricle. Cardiovasc Res. 1985;19:343-354. [Medline] [Order article via Infotrieve]
22. Rhodin JAG. Architecture of the vessel wall. In: Bohr DF, ed. Handbook of Physiology, Volume 2: The Cardiovascular System. Bethesda Md: American Physiological Society; 1980:1-31.
23. Gundersen HJG. The nucleator. J Microsc. 1988;151:3-21. [Medline] [Order article via Infotrieve]
24. Jack EM, Bentley P, Bieri F, Mukkassah-Kelly SF, Stäubli W, Suter J, Waechter F, Cruz-Orive LM. Increase in hepatocyte and nuclear volume and decrease in the population of binucleated cells in praeneoplastic foci of rat liver: a stereological study using the nucleator method. Hepatology. 1990;11:286-297. [Medline] [Order article via Infotrieve]
25. Sterio DC. The unbiased estimation of number and size of arbitrary particles using the dissector. J Microsc. 1984;134:127-136. [Medline] [Order article via Infotrieve]
26. Cruz-Orive LM. Particle number can be estimated using a dissector of unknown thickness, the selector. J Microsc. 1987;145:121-142. [Medline] [Order article via Infotrieve]
27. Sachs L. Angewandte Statistik. Berlin, FRG: Springer-Verlag; 1974.
28.
Olivetti G, Melissari M, Marchetti G, Anversa P. Quantitative
structural changes of the rat thoracic aorta in early spontaneous
hypertension: tissue composition and hypertrophy and hyperplasia of
smooth muscle cells. Circ Res. 1982;51:19-26.
29.
Olivetti G, Anversa P, Melissari M, Loud AV. Morphometric
study of early postnatal development of the thoracic aorta in the rat.
Circ Res. 1980;47:417-424.
30. Todd ME, Laye GG, Osborne DN. The dimensional characteristics of smooth muscle cells in hypertrophic smooth muscle. Acta Physiol Scand. 1983;112:463-471.
31.
Owens GK, Reidy MA. Hyperplastic growth response of vascular
smooth muscle cells following induction of acute hypertension in rats
by aortic coarctation. Circ Res. 1985;57:695-705.
32. Stephans NL, Swynghedau B. Cardiovascular adaptions to mechanical overload. Mol Cell Biochem. 1990;91:1-6.
33.
Kurtz TW, Morris RC Jr. Biological variability in Wistar-Kyoto
rats: implications for research with the spontaneously hypertensive
rat. Hypertension. 1987;10:127-131.
34.
St. Lezin E, Simonet L, Pravenec M, Kurtz TW. Hypertensive
strains and normotensive `control' strains: how closely are they
related? Hypertension. 1992;19:419-424.
35.
Johnson ML, Ely DL, Turner ME. Genetic divergence between the
Wistar-Kyoto rat and the spontaneously hypertensive rat.
Hypertension. 1992;19:425-427.
36.
Lindpaintner K, Kreutz R, Ganten D. Genetic variation in
hypertensive and `control' strains: what are we controlling for
anyway? Hypertension. 1992;19:428-430.
37. Samani NJ, Swates JD, Morton DB, Naftilan AJ, Lindpaintner K, Ganten D, Brammar WJ. DNA fingerprints of spontaneously hypertensive and Wistar-Kyoto rats: implications for hypertension research. J Hypertens. 1989;7:809-816. [Medline] [Order article via Infotrieve]
38. Lee RMKW, Smeda JS, Forrest JB. Ultrastructure and morphometric measurements of mesenteric arteries from newborn spontaneously hypertensive rats. Blood Vessels. 1988;25:105-114. [Medline] [Order article via Infotrieve]
39.
Owens GK, Schwartz SM, McCabba M. Evaluation of medial
hypertrophy in resistance vessels of spontaneously hypertensive rats.
Hypertension. 1988;11:198-207.
40. Loud AV, Anversa P, Giacomelli F, Wiener J. Absolute morphometric study of myocardial hypertrophy in experimental hypertension, I: determination of myocyte size. Lab Invest. 1978;38:586-596. [Medline] [Order article via Infotrieve]
41. Mulvany MJ, Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71:585-596. [Medline] [Order article via Infotrieve]
42.
Smeda JS, Lee RMKW, Forrest JB. Structural and reactivity
alterations of the renal vasculature of spontaneously hypertensive rats
prior to and during established hypertension. Circ Res. 1988;63:518-533.
43.
Scott-Burden T, Resink TJ, Baur U, Burgin M, Bühler FR.
Epidermal growth factor responsiveness in smooth muscle cells from
hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
44.
Adams MA, Bobik A, Korner PJ. Differential development of
vascular and cardiac hypertrophy in genetic hypertension: relation to
sympathetic function. Hypertension. 1989;14:191-202.
45. Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels. 1989;26:1-20.[Medline] [Order article via Infotrieve]
46.
Donohue SJ, Head RJ, Stitzel RE. Elevated nerve growth factor
levels in young spontaneously hypertensive rats.
Hypertension. 1989;14:421-426.
47. Morton JJ, Beattie EC, Griffin SA, MacPherson F. Structural changes during the early onset of experimental hypertension: trophic influences of the renin-angiotensin system. J Hum Hypertens. 1991;5(suppl 1):9-14.
48. Rizzoni D, Castellano M, Porteri E, Betonie G, Muisan ML, Agabiti-Rosei E. Vascular structural and functional alterations before the onset of hypertension in SHR. Am J Hypertens. 1994;7:193-200.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
C. Ootaki, M. Yamashita, Y. Ootaki, K. Kamohara, S. Weber, R. S. Klatte, W. A. Smith, A. L. Massiello, S. N. Emancipator, L. A.R. Golding, et al. Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 150 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Feihl, L. Liaudet, B. I. Levy, and B. Waeber Hypertension and microvascular remodelling Cardiovasc Res, May 1, 2008; 78(2): 274 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sakaguchi, K. Tambara, Y. Sakakibara, M. Ozeki, M. Yamamoto, G. Premaratne, X. Lin, K. Hasegawa, Y. Tabata, K. Nishimura, et al. Control-Released Hepatocyte Growth Factor Prevents the Progression of Heart Failure in Stroke-Prone Spontaneously Hypertensive Rats Ann. Thorac. Surg., May 1, 2005; 79(5): 1627 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin and R. M. Touyz From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446. [Full Text] [PDF] |
||||
![]() |
S.'i. Kihara, K. N. Litwak, L. Nichols, P. Litwak, M. V. Kameneva, Z. Wu, R. L. Kormos, and B. P. Griffith Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist Ann. Thorac. Surg., January 1, 2003; 75(1): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Dries, D. V. Exner, B. J. Gersh, H. A. Cooper, P. E. Carson, and M. J. Domanski Racial Differences in the Outcome of Left Ventricular Dysfunction N. Engl. J. Med., February 25, 1999; 340(8): 609 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. TÖRNIG, M.-L. GROSS, A. SIMONAVICIENE, G. MALL, E. RITZ, and K. AMANN Hypertrophy of Intramyocardial Arteriolar Smooth Muscle Cells in Experimental Renal Failure J. Am. Soc. Nephrol., January 1, 1999; 10(1): 77 - 83. [Abstract] [Full Text] |
||||
![]() |
M. R. Weir, S. G. Chrysant, D. A. McCarron, M. Canossa-Terris, J. D. Cohen, P. A. Gunter, A. J. Lewin, R. F. Mennella, L. W. Kirkegaard, J. H. Hamilton, et al. Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives Hypertension, May 1, 1998; 31(5): 1088 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, A. Moriguchi, R. Morishita, I. Kida, N. Tomita, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara Role of Angiotensin II in the Regulation of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Experimental Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1448 - 1454. [Abstract] [Full Text] |
||||
![]() |
K. Amann, B. Wolf, C. Nichols, J. Tornig, U. Schwarz, M. Zeier, G. Mall, and E. Ritz Aortic Changes in Experimental Renal Failure: Hyperplasia or Hypertrophy of Smooth Muscle Cells? Hypertension, March 1, 1997; 29(3): 770 - 775. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |